Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M102,926Revenue $M41,414Net Margin (%)17.6Z-Score2.1
Enterprise Value $M128,162EPS $3.5Operating Margin %22.5F-Score6
P/E(ttm))16.2Cash Flow Per Share $0Pre-tax Margin (%)21.0Higher ROA y-yY
Price/Book13.210-y EBITDA Growth Rate %3.1Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %2.4Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-22.6ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %6.2Insider Buy (3m)0ROE % (ttm)68.0Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M2,402ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKHOTCHKIS & WILEY 2014-09-30 Add0.98%$46.29 - $54.52
($49.01)
$ 42.85-13%Add 118.31%10,804,564
GSKCharles Brandes 2014-09-30 Add0.56%$46.29 - $54.52
($49.01)
$ 42.85-13%Add 36.63%3,415,717
GSKIrving Kahn 2014-09-30 Buy 0.38%$46.29 - $54.52
($49.01)
$ 42.85-13%New holding, 51000 sh.51,000
GSKNWQ Managers 2014-09-30 Add0.03%$46.29 - $54.52
($49.01)
$ 42.85-13%Add 39.82%208,125
GSKDavid Dreman 2014-09-30 Buy 0.01%$46.29 - $54.52
($49.01)
$ 42.85-13%New holding, 1328 sh.1,328
GSKDodge & Cox 2014-09-30 Reduce-1.11%$46.29 - $54.52
($49.01)
$ 42.85-13%Reduce -35.93%38,589,161
GSKHOTCHKIS & WILEY 2014-06-30 Add0.93%$51.55 - $56.39
($54.16)
$ 42.85-21%Add 13358.6%4,949,118
GSKCharles Brandes 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 42.85-21%Add 15.52%2,500,048
GSKJohn Rogers 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 42.85-21%Add 49.33%988,772
GSKJames Barrow 2014-06-30 Buy 0.02%$51.55 - $56.39
($54.16)
$ 42.85-21%New holding, 270900 sh.270,900
GSKPRIMECAP Management 2014-06-30 Reduce-0.25%$51.55 - $56.39
($54.16)
$ 42.85-21%Reduce -43.82%5,156,449
GSKJohn Rogers 2014-03-31 Add0.16%$50.9 - $56.66
($54.07)
$ 42.85-21%Add 57.21%662,150
GSKHOTCHKIS & WILEY 2014-03-31 Buy 0.01%$50.9 - $56.66
($54.07)
$ 42.85-21%New holding, 36773 sh.36,773
GSKJohn Hussman 2014-03-31 Reduce-0.38%$50.9 - $56.66
($54)
$ 42.85-21%Reduce -23.61%323,500
GSKVanguard Health Care Fund 2014-03-31 Sold Out -0.11%$50.9 - $56.66
($54)
$ 42.85-21%Sold Out0
GSKNWQ Managers 2014-03-31 Reduce-0.03%$50.9 - $56.66
($54.07)
$ 42.85-21%Reduce -28.91%148,800
GSKJohn Hussman 2013-12-31 Add1.51%$49.31 - $53.68
($51.87)
$ 42.85-17%Add 1702.13%423,500
GSKJohn Rogers 2013-12-31 Add0.19%$49.31 - $53.68
($51.87)
$ 42.85-17%Add 208.93%421,201
GSKCharles Brandes 2013-12-31 Add0.16%$49.31 - $53.68
($51.87)
$ 42.85-17%Add 13.11%2,145,461
GSKJoel Greenblatt 2013-12-31 Buy 0.11%$49.31 - $53.68
($51.87)
$ 42.85-17%New holding, 83452 sh.83,452
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GSK Irving Kahn 2014-09-3051,00000.38New Buy
GSK David Dreman 2014-09-301,32800.01New Buy
GSK HOTCHKIS & WILEY 2014-09-3010,804,5640.451.8+118.31%
GSK NWQ Managers 2014-09-30208,1250.010.11+39.82%
GSK Charles Brandes 2014-09-303,415,7170.142.1+36.63%
GSK John Rogers 2014-09-301,005,6340.040.6+1.71%
GSK Ken Fisher 2014-09-3011,488,5940.481.1+1.08%
GSK James Barrow 2014-09-30270,9000.010.02
GSK John Hussman 2014-09-30323,5000.011.3
GSK Jean-Marie Eveillard 2014-09-30100
GSK Joel Greenblatt 2014-09-3083,46200.04-0.08%
GSK Tweedy Browne 2014-09-30140,2780.010.15-1.29%
GSK PRIMECAP Management 2014-09-304,874,6350.20.24-5.47%
GSK Dodge & Cox 2014-09-3038,589,1611.611.7-35.93%
Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29721.17view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12262view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14210.29view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12262view

Press Releases about GSK :

    Quarterly/Annual Reports about GSK:

      News about gsk:

      Articles On GuruFocus.com
      tester Dec 18 2014 
      Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR Dec 14 2014 
      Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
      The Top 5 European Stocks Held During Q3 Nov 25 2014 
      Jeff Auxier Buys Berkshire Hathaway in Third Quarter Nov 18 2014 
      Irving Kahn Starts New Position In GlaxoSmithKline Nov 13 2014 
      Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014 Nov 12 2014 
      Kahn Brothers' Third Quarter Numbers Nov 07 2014 
      Tweedy Browne Global Value Fund's Top Picks for Q3 Oct 21 2014 
      Diamond Hill Capital Comments on GlaxoSmithKline PLC Oct 17 2014 


      More From Other Websites
      Why GlaxoSmithKline plc Is Down 17% This Year Dec 23 2014
      ’Tis the season for buying stocks dumped for tax reasons Dec 22 2014
      Could GlaxoSmithKline plc Become A Perilous Value Trap? Dec 22 2014
      GlaxoSmithKline (GSK) Stock Rises Today on Positive Experimental Shingles Vaccine Trial Results Dec 18 2014
      Glaxo Says Dividend Is Secure as Analysts Question Payout Dec 18 2014
      Positive Outcome of Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant Dec 18 2014
      Will GlaxoSmithKline plc And AstraZeneca plc Make You Rich In 2015? Dec 18 2014
      Mr Market Has Changed His Mind About GlaxoSmithKline plc and AstraZeneca plc, But Should You? Dec 17 2014
      3 Stocks That Could Surge By 25%+ Next Year! GlaxoSmithKline plc, Sports Direct International Plc... Dec 16 2014
      Is GlaxoSmithKline plc Worth £20 Or Less Than A Tenner? Dec 15 2014
      HFF closes sale of BioMed Realty Trust life sciences facility in Rockville, Maryland Dec 12 2014
      Should You Buy Shares In GlaxoSmithKline plc, Centrica PLC And BHP Billiton plc After 2014’s... Dec 12 2014
      Stock pro Bhansali: Opportunity abroad in '15 Dec 11 2014
      Newest HPV Vaccine Protects Against 9 Strains Dec 11 2014
      Something Strange Is Going On At GlaxoSmithKline plc… Dec 11 2014
      GSK Changes Its Drug Sales Practices And R&D Suffers Dec 10 2014
      GlaxoSmithKline plc Vs AstraZeneca: Which Pharma Major Will Win In 2015? Dec 09 2014
      How to Trade Foreign Stocks Without Leaving the U.S. Dec 09 2014
      Is GlaxoSmithKline plc Still A Buy After Its Failed Sale? Dec 05 2014
      British drugmaker cutting hundreds of US jobs Dec 04 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK